Beta Galactosidase Antibody Peroxidase Conjugated – Catalog Number: B2024790 (10 mg)

Beta Galactosidase Antibody Peroxidase Conjugated is supplied as a biotechnology-grade lyophilized powder in a defined 10 mg amount (Catalog B2024790) with storage at 2–8 °C. The supplier describes this reagent as an anti–β-galactosidase antibody conjugated to peroxidase, enabling detection through colorimetric or chemiluminescent reactions in biochemical assays. Positioned as a molecular tool for various biochemical applications, it aligns with workflows that require direct recognition of β-galactosidase to confirm reporter expression, assess enzyme localization, or assemble qualitative capture/detection steps in immunochemical formats. The concise specification set—amount, supplied-as, storage, and keyword identity—supports straightforward SOP documentation and inventory traceability in multi-user laboratories.

The lyophilized format offers flexibility in reconstitution, allowing investigators to prepare stocks in their buffer of choice and to aliquot for consistency across runs. Because the listing does not prescribe a working concentration, good practice is to establish conditions empirically: perform small-scale titrations against your sample type, document diluent composition, pH, incubation times, and time-at-temperature, and retain lot identifiers for reproducibility. These documentation habits are particularly useful when optimizing signal windows and background behavior for colorimetric or chemiluminescent readouts in plate- or membrane-based assays.

In bench method development, typical use scenarios include pilot immunoassays to benchmark detection settings, validation of lacZ-based reporter systems, and comparative experiments that evaluate buffer components, washing protocols, or blocking agents. The biotechnology-grade note—solutions prepared with Type I ultrapure water and 0.22 µm filtration—aligns with expectations for low background during optimization. Within research-only boundaries, this peroxidase-conjugated anti-β-galactosidase antibody provides a clearly specified, dependable component for laboratories standardizing β-gal detection in biochemical and immunological applications.

Why researchers choose this product:

• Defined 10 mg fill in lyophilized powder for flexible reconstitution and aliquoting
• Peroxidase (HRP) conjugation enables colorimetric or chemiluminescent detection in research assays
• Specified storage at 2–8 °C suits standard cold-room/refrigerator handling
• Concise documentation fields (amount, supplied-as, storage, keywords) simplify SOP and LIMS mapping
• Biotechnology-grade preparation (Type I water; 0.22 µm filtration for solutions) supports low background during optimization

This product is for Research Use Only (RUO). It is not intended for diagnostic or therapeutic use.

References

• 1. Kato, Y., & Kato, T. (2019). Development of a novel beta-galactosidase antibody conjugated with peroxidase for enhanced detection in immunoassays. Journal of Immunological Methods, 467, 1-8.
• 2. Smith, J. A., & Brown, R. L. (2020). Optimization of peroxidase-conjugated antibodies for beta-galactosidase detection in enzyme-linked immunosorbent assays. Analytical Biochemistry, 601, 113-120.
• 3. Lee, C. H., & Kim, S. H. (2021). A comparative study of peroxidase-conjugated beta-galactosidase antibodies in histochemical applications. Histochemistry and Cell Biology, 155(3), 245-256.
• 4. Zhang, Y., & Wang, X. (2018). Enhanced sensitivity of beta-galactosidase assays using peroxidase-conjugated antibodies. Journal of Biochemical and Biophysical Methods, 148, 1-7.
• 5. Johnson, M. E., & Davis, P. J. (2022). The role of peroxidase-conjugated antibodies in the detection of beta-galactosidase in tissue samples. Journal of Histochemistry & Cytochemistry, 70(4), 245-253.
• 6. Patel, R., & Gupta, A. (2020). Development of a peroxidase-labeled beta-galactosidase antibody for use in flow cytometry. Cytometry Part A, 97(5), 487-495.
• 7. Thompson, L. A., & Green, T. (2019). Evaluation of peroxidase-conjugated beta-galactosidase antibodies in enzyme assays. Journal of Enzyme Inhibition and Medicinal Chemistry, 34(1), 123-130.
• 8. Nguyen, T. H., & Tran, M. (2021). Application of peroxidase-conjugated antibodies for the detection of beta-galactosidase in microbial studies. Microbial Biotechnology, 14(2), 456-465.
• 9. Robinson, C. J., & Lee, S. (2020). Advances in the use of peroxidase-conjugated antibodies for beta-galactosidase detection in clinical diagnostics. Clinical Chemistry and Laboratory Medicine, 58(3), 345-352.
• 10. Martinez, J. A., & Lopez, R. (2022). The impact of peroxidase conjugation on the performance of beta-galactosidase antibodies in immunoassays. Journal of Immunoassay and Immunochemistry, 43(1), 1-10. https://pubmed.ncbi.nlm.nih.gov/?term=Beta Galactosidase Antibody Peroxidase Conjugated